QS Investors, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$542,000
-80.2%
31,104
-80.8%
0.01%
-81.6%
Q2 2020$2,732,000
+41.4%
162,4120.0%0.04%
+22.6%
Q1 2020$1,932,000
-4.4%
162,412
-3.1%
0.03%
+55.0%
Q4 2019$2,021,000
-16.2%
167,573
-1.7%
0.02%
-23.1%
Q3 2019$2,411,000
+26.8%
170,5240.0%0.03%
+23.8%
Q2 2019$1,902,000
-6.6%
170,524
-1.7%
0.02%
-4.5%
Q1 2019$2,037,000
-12.7%
173,470
-0.6%
0.02%
-26.7%
Q4 2018$2,332,000
-4.7%
174,4800.0%0.03%
+25.0%
Q3 2018$2,446,000
-11.3%
174,480
-0.6%
0.02%
-11.1%
Q2 2018$2,759,000
-4.4%
175,493
+0.0%
0.03%
-10.0%
Q1 2018$2,887,000
-14.8%
175,478
-6.5%
0.03%
-6.2%
Q4 2017$3,390,000
-9.7%
187,709
-3.5%
0.03%
+6.7%
Q3 2017$3,754,000
+31183.3%
194,492
+19099.6%
0.03%
Q2 2017$12,000
+9.1%
1,0130.0%0.00%
Q1 2017$11,000
+57.1%
1,0130.0%0.00%
Q4 2016$7,0000.0%1,0130.0%0.00%
Q3 2016$7,000
+16.7%
1,0130.0%0.00%
Q2 2016$6,000
+20.0%
1,0130.0%0.00%
Q1 2016$5,0000.0%1,0130.0%0.00%
Q4 2015$5,000
+25.0%
1,0130.0%0.00%
Q3 2015$4,0001,0130.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,951,077$178,226,0009.95%
Parallel Advisors, LLC 3,769,455$96,649,0004.45%
Novo Holdings A/S 3,327,768$85,324,0004.07%
TANAKA CAPITAL MANAGEMENT INC 35,539$911,0002.72%
Quantedge Capital Pte Ltd 243,712$6,249,0001.93%
S&T BANK/PA 349,456$8,960,0001.73%
Birchview Capital, LP 50,000$1,282,0000.90%
Bridge City Capital, LLC 61,254$1,571,0000.86%
FAS Wealth Partners, Inc. 299,576$7,681,0000.85%
AJ WEALTH STRATEGIES, LLC 509,934$13,075,0000.76%
View complete list of CORCEPT THERAPEUTICS INC shareholders